Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 3322650

Pulmonary function testing in children.

J D Eisenberg·M A Wall
View original source ↗Export metadata ↓

Abstract

This article concentrates on those factors that are particularly important for performing and interpreting lung function tests in children. Specifically, technical considerations such as equipment, personnel, test performance, and bronchoprovocation procedures are discussed. Changes in lung function with growth and appropriate use of race-specific reference standards are emphasized, and references for standard and experimental pulmonary function tests are provided. Several examples illustrating the utility of pulmonary function testing in clinical situations in children with lung disease are provided as well.

Explore related subjects

Blood Gas AnalysisChildChild DevelopmentChild, PreschoolFemaleHumansInfant, NewbornLung DiseasesMaleReference ValuesRespiratory Function TestsCase ReportsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J D Eisenberg, M A Wall. 1987. Pulmonary function testing in children.. https://pubmed.ncbi.nlm.nih.gov/3322650/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

[Capnometry].

Technological advances during recent years and developments in anaesthesiology and intensive care have increased the interest in capnometry (measuring the CO2 content in the respiratory air). The physiological background and the principles of the method are presented. The applicability in clinical work and the limits of the method are presented and discussed.

Blood Gas Analysis↗
PubMed1992

[Long-term oxygen therapy in chronic respiratory insufficiency. Usefulness, indications, modes of administration].

Long-term oxygen therapy improves the life expectancy of hypoxaemic patients with chronic obstructive pulmonary disease (COPD), provided the hypoxaemia is sufficiently pronounced under stable conditions (PaO2 less than 55 mmHg) and oxygen is given for more than 16 out of 24 hours. By extension, the same indications are applicable to hypoxaemia due to other causes (diffuse fibrosis, pneumoconiosis, cystic fibrosis, etc.). Long-term oxygen therapy improves the patients' quality of life and also has favourable effects on oxygen transport, neuropsychological status, polycythaemia and pulmonary hypertension. It is usually delivered by means of O2 extractors, to which may be added small flasks of O2 gas for walking and moving about. Liquid O2 is a good solution for subjects who are motivated and are obliged to do a great deal of walking. The O2 flow rate administered must be such that it rises the PaO2 level above 60 mmHg. Oxygen therapy is only a symptomatic treatment and cannot replace other types of therapy, such as bronchodilators, physiotherapy, etc. It gives satisfactory results but it has not transformed the prognosis of severe hypoxaemic COPD.

Blood Gas Analysis↗